Reviewing the Compounding Risks for Tuberculosis Drug-Induced Liver Injury in a Patient with Transfusion Dependent Thalassaemia
Year: 2023
Type: article
Abstract: A patient presents with jaundice three weeks into commencement of anti-tuberculosis therapy (ATT). Tuberculosis drug-induced liver injury (TB-DILI) is a main concern in patients commencing ATT. Studies have reported various risk factors associated with TB-DILI, urging vigilance in monitoring liver enzymes in these patients. We aim to review the causes of jaundice in a patient with transfusion dependent thalassaemia commenced on ATT and highlight the risk factors associated with TB-DILI.
Authors: Nursafinas Rofii, Ummi Nadira Daut, Su Yin Lau
Institution: Universiti Putra Malaysia
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W4387754367